Read an expert analysis from Zofia Piotrowska MD and Natasha Leighl MD MMSc FRCPC FASCO discussing the clinical implications of key lung cancer studies presented at the 2024 ASCO Annual Meeting
- Provider:Clinical Care Options
- Activity Link: https://clinicaloptions.com/CE-CME/oncology/asco-2024-lung-cancer/22631-47761
- Start Date: 2024-08-23 05:00:00
- End Date: 2024-08-23 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: Source: AstraZeneca (Any division) - Amount: 16666.67 - Is Kind Support: False Source: Daiichi Sankyo, Inc. - Amount: 16666.67 - Is Kind Support: False Source: Gilead Sciences, Inc. - Amount: 26666.67 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest